Page 42 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

40
Chapter 2
References
1 Bradley PJ, McGurk M. Incidence of salivary gland neoplasms in a defined UK population. Br J Oral Maxillofac Surg 2013; 51: 399-403
2 Przewoźny T, Stankiewicz C. Neoplasms of the parotid gland in northern Poland, 1991-2000: an epidemiologic study. Eur Arch Otorhinolaryngol 2004; 261: 369-375
3 Spiro R. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986; 8: 177-184
4 Andreasen S, Therkildsen MH, Bjørndal K, et al. Pleomorphic adenoma of the parotid gland 1985- 2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck 2016; 38: E1364-9
5 Zbären P, Vander Poorten V, Witt RL, et al. Pleomorphic adenoma of the parotid: Formal parotidectomy or limited surgery? Am J Surg 2013; 205: 109-118
6 Witt RL, Eisele DW, Morton RP, et al. Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope October 2014: 1-6
7 Albergotti W, Nguyen S, Zenk J, et al. Extracapsular dissection for benign parotid tumors: a meta- analysis. Laryngoscope 2012; 122: 1954-1960
8 Chen AM, Garcia J, Bucci MK, et al. Recurrent pleomorphic adenoma of the parotid gland: long-term outcome of patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006; 66: 1031-1035
9 Wallace AS, Morris CG, Kirwan JM, et al. Radiotherapy for pleomorphic adenoma. Am J Otolaryngol 2013; 34: 36-40
10 Gnepp D. Malignant mixed tumors of the salivary glands: a review. Pathol Annu 1993; 28: 279-328
11 de Ridder M, Balm AJM, Smeele LE, et al. An epidemiological evaluation of salivary gland cancer in
the Netherlands (1989-2010). Cancer Epidemiol 2015; 39: 14-20
12 M.H. Valstar, M. de Ridder, M.L.F. van Velthuysen, L.I.H. Overbeek, B.A.C. van Dijk, A.J.M. Balm LES. Salivary gland pleomorphic adenoma: a 20-year incidence study. In Ramsay-Baggs P, ed. XXII Congress of the European Association for Cranio-Maxillo-Facial Surgery; Book of Abstracts. Prague: Provided Services s.r.o, 2014; 310.
13 Tuckers A, Ekstroem J, Khosravani N. Embryology and clinical anatomy; Regulatory mechanisms and salivary gland functions. In Bradley P, Guntinas-Lichius O, eds. Salivary Gland Disorders and Diseases: Diagnosis and Management. 1st ed. Stuttgart and New York: Thieme, 2011; 180.
14 Gunn P. Parotid Tumors Northern Regional Health Authority of the United Kingdom 1978-1982. Br J Surg 1988; 75: 1144-1146
15 Pinkston J a, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 1999; 120: 834-840
16 Moeller K, Esser D, Boeger D, et al. Parotidectomy and submandibulectomy for benign diseases in Thuringia, Germany: a population-based study on epidemiology and outcome. Eur Arch Otorhinolaryngol 2013; 270: 1149-1155
17 Mortensen KS1, Hjortlund J, Bjørndal K, Krogdal A GC. Salivary gland tumors in the County of Funen, 1984-2003. Ugeskr Laeger 2008; 170: 545-548
18 Statistics Netherlands, Central Bureau of Statistics (CBS). [Accessed December 15, 2015] Available from: http://statline.cbs.nl/statweb.
19 Pace M, Lanzieri G GM et al. Revision of the European Standardized Population. Report of Eurostat’s Task Force. Eurostat’s Methodologies and Working Papers.; 2013.
20 Waterhouse JAH, Muir CS CP et al. Cancer incidence in five continents. 3: 456
21 R Core Team. R Foundation Statistical Computing, Vienna A. R: A language and environment for
statistical computing.
22 Van Buuren S G-OK. Mice: Multivariate Imputation by Chained Equations. R J Stat Software, 45(3),
1-67 2011
23 Benaglia, T., Chauveau, D., Hunter, D. R., and Young D. Mixtools: An R package for analyzing finite mixture models. J Stat Softw 2009; 32: 1-29